Furthermore, in a seminal longitudinal study which attempted to identify a gene signature associated with high-risk for HCC (using transcriptome meta-analysis) in patients suffering from cirrhosis of all major etiologies (hepatitis B/C, alcohol, and NASH), LPA pathway activation was robustly observed in patients with high HCC risk [155]. The gene discussed is LPA; the disease is hepatocellular carcinoma.